LifeTech Scientific Corporation (HKG: 1302)

Market Cap	6.44B
Revenue (ttm)	1.38B
Net Income (ttm)	267.16M
Shares Out	4.63B
EPS (ttm)	0.06
PE Ratio	23.20
Forward PE	18.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,304,000
Open	1.390
Previous Close	1.390
Day's Range	1.240 - 1.390
52-Week Range	1.240 - 2.630
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,448
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2023, LifeTech Scientific's revenue was 1.27 billion, an increase of 15.48% compared to the previous year's 1.10 billion. Earnings were 263.24 million, a decrease of -19.09%.

Financial numbers in CNY